Concepedia

Christos Karkantaris

CK

Statistics

Publications

7

Citations

530

H-Index

7

Active since

2001

Affiliations

Laiko General Hospital of Athens(Current)

National and Kapodistrian University of Athens

Hammersmith Hospital

Christos Karkantaris is an author at Laiko General Hospital of Athens specializing in medicine, hematologic malignancy therapy, and hodgkin lymphoma therapy.

Publications per year

2001–2005

7

Publications

7

Treatment of Waldenström’s Macroglobulinemia With Rituximab

Meletios Α. Dimopoulos, Constantinos Zervas, Athanassios Zomas et al. · Journal of Clinical Oncology · 2002 · 254 citations

, , +13

The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio

Evangelos Terpos, Dimitra Mihou, Richard Szydlo et al. · Leukemia · 2005 · 103 citations

, , +14

Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin‐6 and β<sub>2</sub>‐microglobulin in multiple myeloma

Evangelos Terpos, Nora Viniou, Josu de la Fuente et al. · European Journal Of Haematology · 2003 · 54 citations

, , +16

The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.

Theodoros P. Vassilakopoulos, Gianpaolo Nadali, Maria K. Angelopoulou et al. · PubMed · 2002 · 49 citations

, , +16

Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites

T. P. Vassilakopoulos, Maria K. Angelopoulou, Marina P. Siakantaris et al. · European Journal Of Haematology · 2001 · 37 citations

, , +16

1–5 of 7